Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell of lymphatic vessel | 16 studies | 35% ± 15% | |
endothelial cell | 7 studies | 26% ± 10% | |
endothelial cell of vascular tree | 6 studies | 27% ± 9% | |
myeloid cell | 4 studies | 27% ± 8% | |
Mueller cell | 4 studies | 25% ± 5% | |
fibroblast | 4 studies | 26% ± 4% | |
vein endothelial cell | 4 studies | 26% ± 8% | |
squamous epithelial cell | 3 studies | 31% ± 12% | |
classical monocyte | 3 studies | 23% ± 4% | |
astrocyte | 3 studies | 29% ± 8% | |
connective tissue cell | 3 studies | 24% ± 5% |
Insufficient scRNA-seq data for expression of SPHK1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 99% | 2039.84 | 453 / 459 | 93% | 24.28 | 1040 / 1118 |
pancreas | 98% | 861.07 | 320 / 328 | 94% | 34.44 | 167 / 178 |
thymus | 99% | 1274.19 | 647 / 653 | 91% | 16.82 | 549 / 605 |
skin | 100% | 2325.51 | 1809 / 1809 | 89% | 28.10 | 422 / 472 |
esophagus | 99% | 1440.32 | 1434 / 1445 | 87% | 28.27 | 160 / 183 |
uterus | 93% | 715.15 | 158 / 170 | 92% | 38.73 | 421 / 459 |
lung | 100% | 2634.64 | 577 / 578 | 83% | 20.56 | 961 / 1155 |
bladder | 90% | 1175.29 | 19 / 21 | 72% | 21.47 | 365 / 504 |
intestine | 87% | 700.87 | 838 / 966 | 62% | 11.20 | 326 / 527 |
stomach | 53% | 545.01 | 190 / 359 | 70% | 10.57 | 199 / 286 |
prostate | 94% | 874.41 | 230 / 245 | 24% | 1.99 | 121 / 502 |
ovary | 62% | 409.23 | 111 / 180 | 49% | 5.84 | 212 / 430 |
kidney | 58% | 722.58 | 52 / 89 | 47% | 9.51 | 422 / 901 |
lymph node | 0% | 0 | 0 / 0 | 100% | 22.22 | 29 / 29 |
tonsil | 0% | 0 | 0 / 0 | 100% | 41.18 | 45 / 45 |
adipose | 99% | 1869.59 | 1195 / 1204 | 0% | 0 | 0 / 0 |
spleen | 94% | 560.16 | 226 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 88% | 1209.96 | 1179 / 1335 | 0% | 0 | 0 / 0 |
heart | 80% | 1025.90 | 689 / 861 | 0% | 0 | 0 / 0 |
brain | 21% | 159.01 | 545 / 2642 | 52% | 7.59 | 364 / 705 |
eye | 0% | 0 | 0 / 0 | 70% | 11.49 | 56 / 80 |
adrenal gland | 53% | 312.08 | 137 / 258 | 15% | 3.32 | 34 / 230 |
liver | 19% | 154.86 | 42 / 226 | 42% | 17.90 | 172 / 406 |
peripheral blood | 53% | 294.90 | 491 / 929 | 0% | 0 | 0 / 0 |
muscle | 18% | 95.56 | 146 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_1903978 | Biological process | regulation of microglial cell activation |
GO_0030148 | Biological process | sphingolipid biosynthetic process |
GO_1901224 | Biological process | positive regulation of non-canonical NF-kappaB signal transduction |
GO_0006670 | Biological process | sphingosine metabolic process |
GO_0048146 | Biological process | positive regulation of fibroblast proliferation |
GO_0006954 | Biological process | inflammatory response |
GO_0008283 | Biological process | cell population proliferation |
GO_0150077 | Biological process | regulation of neuroinflammatory response |
GO_0019722 | Biological process | calcium-mediated signaling |
GO_0030307 | Biological process | positive regulation of cell growth |
GO_0045766 | Biological process | positive regulation of angiogenesis |
GO_0010803 | Biological process | regulation of tumor necrosis factor-mediated signaling pathway |
GO_0034612 | Biological process | response to tumor necrosis factor |
GO_0071363 | Biological process | cellular response to growth factor stimulus |
GO_1900745 | Biological process | positive regulation of p38MAPK cascade |
GO_0070301 | Biological process | cellular response to hydrogen peroxide |
GO_0045931 | Biological process | positive regulation of mitotic cell cycle |
GO_0051092 | Biological process | positive regulation of NF-kappaB transcription factor activity |
GO_0003376 | Biological process | sphingosine-1-phosphate receptor signaling pathway |
GO_0045987 | Biological process | positive regulation of smooth muscle contraction |
GO_0071897 | Biological process | DNA biosynthetic process |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_0032651 | Biological process | regulation of interleukin-1 beta production |
GO_1900060 | Biological process | negative regulation of ceramide biosynthetic process |
GO_0046512 | Biological process | sphingosine biosynthetic process |
GO_0001568 | Biological process | blood vessel development |
GO_0030100 | Biological process | regulation of endocytosis |
GO_0007420 | Biological process | brain development |
GO_0050764 | Biological process | regulation of phagocytosis |
GO_0031398 | Biological process | positive regulation of protein ubiquitination |
GO_0016310 | Biological process | phosphorylation |
GO_0010800 | Biological process | positive regulation of peptidyl-threonine phosphorylation |
GO_0006473 | Biological process | protein acetylation |
GO_0046521 | Biological process | sphingoid catabolic process |
GO_0035924 | Biological process | cellular response to vascular endothelial growth factor stimulus |
GO_0045840 | Biological process | positive regulation of mitotic nuclear division |
GO_0032740 | Biological process | positive regulation of interleukin-17 production |
GO_1905364 | Biological process | regulation of endosomal vesicle fusion |
GO_0098793 | Cellular component | presynapse |
GO_0005886 | Cellular component | plasma membrane |
GO_0030139 | Cellular component | endocytic vesicle |
GO_0016020 | Cellular component | membrane |
GO_0031901 | Cellular component | early endosome membrane |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005905 | Cellular component | clathrin-coated pit |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0051721 | Molecular function | protein phosphatase 2A binding |
GO_0008289 | Molecular function | lipid binding |
GO_0017050 | Molecular function | D-erythro-sphingosine kinase activity |
GO_0000287 | Molecular function | magnesium ion binding |
GO_0001727 | Molecular function | lipid kinase activity |
GO_0016407 | Molecular function | acetyltransferase activity |
GO_0008481 | Molecular function | sphinganine kinase activity |
GO_0038036 | Molecular function | sphingosine-1-phosphate receptor activity |
GO_0005524 | Molecular function | ATP binding |
GO_0005516 | Molecular function | calmodulin binding |
GO_0005515 | Molecular function | protein binding |
Gene name | SPHK1 |
Protein name | Sphingosine kinase 1 Sphingosine kinase 1 (cDNA FLJ78254) SPHK1 protein Sphingosine kinase 1 (SK 1) (SPK 1) (EC 2.7.1.91) (Acetyltransferase SPHK1) (EC 2.3.1.-) |
Synonyms | hCG_30901 SK1 SPHK SPK |
Description | FUNCTION: Catalyzes the phosphorylation of sphingosine to form sphingosine 1-phosphate (SPP), a lipid mediator with both intra- and extracellular functions. Also acts on D-erythro-sphingosine and to a lesser extent sphinganine, but not other lipids, such as D,L-threo-dihydrosphingosine, N,N-dimethylsphingosine, diacylglycerol, ceramide, or phosphatidylinositol . In contrast to proapoptotic SPHK2, has a negative effect on intracellular ceramide levels, enhances cell growth and inhibits apoptosis . Involved in the regulation of inflammatory response and neuroinflammation. Via the product sphingosine 1-phosphate, stimulates TRAF2 E3 ubiquitin ligase activity, and promotes activation of NF-kappa-B in response to TNF signaling leading to IL17 secretion . In response to TNF and in parallel to NF-kappa-B activation, negatively regulates RANTES induction through p38 MAPK signaling pathway . Involved in endocytic membrane trafficking induced by sphingosine, recruited to dilate endosomes, also plays a role on later stages of endosomal maturation and membrane fusion independently of its kinase activity . In Purkinje cells, seems to be also involved in the regulation of autophagosome-lysosome fusion upon VEGFA . .; FUNCTION: Has serine acetyltransferase activity on PTGS2/COX2 in an acetyl-CoA dependent manner. The acetyltransferase activity increases in presence of the kinase substrate, sphingosine. During neuroinflammation, through PTGS2 acetylation, promotes neuronal secretion of specialized preresolving mediators (SPMs), especially 15-R-lipoxin A4, which results in an increase of phagocytic microglia. . |
Accessions | K7EJ32 K7EMA4 ENST00000590379.5 ENST00000588682.5 Q9BTG7 Q53ZR5 Q9NYA1 ENST00000592299.6 [Q9NYA1-1] ENST00000590959.5 [Q9NYA1-3] ENST00000545180.5 [Q9NYA1-1] ENST00000392496.3 [Q9NYA1-1] ENST00000323374.8 [Q9NYA1-2] |